MX2021003356A - Dispositivo ingerible con recinto expandible. - Google Patents
Dispositivo ingerible con recinto expandible.Info
- Publication number
- MX2021003356A MX2021003356A MX2021003356A MX2021003356A MX2021003356A MX 2021003356 A MX2021003356 A MX 2021003356A MX 2021003356 A MX2021003356 A MX 2021003356A MX 2021003356 A MX2021003356 A MX 2021003356A MX 2021003356 A MX2021003356 A MX 2021003356A
- Authority
- MX
- Mexico
- Prior art keywords
- region
- expanded
- ingestible device
- dimension
- expandable enclosure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1054—Balloon catheters with special features or adapted for special applications having detachable or disposable balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/1053—Stomach
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/106—Small intestine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Una modalidad de un dispositivo ingerible para el suministro de un agente terapéutico incluye una cubierta exterior para tragar y un mecanismo de suministro dentro de la cubierta exterior. El mecanismo de suministro incluye un recinto expandible. El mecanismo de suministro puede activarse in situ dentro de un tracto gastrointestinal (GI) de un cuerpo para expandir múltiples regiones del recinto expandible a un estado expandido en una ubicación de suministro dentro del cuerpo. Las múltiples regiones incluyen una región principal y una región de cola con una cavidad protectora definida entre la región principal y la región de cola, y una región de retención dentro de la cavidad protectora. Una dimensión de la región de retención expandida es menor que una dimensión de la región principal expandida y menor que una dimensión de la región de cola expandida. El dispositivo ingerible incluye una composición formada dispuesta en la región de retención.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862736263P | 2018-09-25 | 2018-09-25 | |
US16/579,112 US20200093740A1 (en) | 2018-09-25 | 2019-09-23 | Ingestible device with expandable enclosure |
PCT/US2019/052718 WO2020068842A1 (en) | 2018-09-25 | 2019-09-24 | Ingestible device with expandable enclosure |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021003356A true MX2021003356A (es) | 2021-08-11 |
Family
ID=69885716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021003356A MX2021003356A (es) | 2018-09-25 | 2019-09-24 | Dispositivo ingerible con recinto expandible. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20200093740A1 (es) |
EP (1) | EP3856153A4 (es) |
JP (2) | JP7334242B2 (es) |
KR (1) | KR20210064298A (es) |
CN (1) | CN113164399A (es) |
AU (1) | AU2019346545A1 (es) |
BR (1) | BR112021005449A2 (es) |
CA (1) | CA3113987A1 (es) |
MX (1) | MX2021003356A (es) |
WO (1) | WO2020068842A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
AU2021351884A1 (en) * | 2020-09-30 | 2023-03-16 | Novo Nordisk A/S | A swallowable capsule device |
CN114099921B (zh) * | 2021-11-04 | 2022-07-22 | 北京理工大学 | 一种体内弯曲区域爆炸冲击释药含能微系统 |
EP4209208A1 (en) * | 2022-01-06 | 2023-07-12 | ETH Zurich | Swallowable, self-expandable drug delivery device and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050058701A1 (en) * | 2003-01-29 | 2005-03-17 | Yossi Gross | Active drug delivery in the gastrointestinal tract |
JP2006517827A (ja) * | 2003-01-29 | 2006-08-03 | イー−ピル・ファーマ・リミテッド | 胃腸管内における活性薬物の送達 |
US6981980B2 (en) * | 2003-03-19 | 2006-01-03 | Phagia Technology | Self-inflating intragastric volume-occupying device |
AU2005272597B2 (en) * | 2004-08-13 | 2011-03-03 | Obalon Therapeutics, Inc. | Intragastric volume-occupying device |
EP1827387A2 (en) * | 2004-12-14 | 2007-09-05 | E-Pill Pharma Ltd. | Prolonged transit time of permeability-enhancing drug eluting pill |
US8287902B2 (en) * | 2008-07-23 | 2012-10-16 | Rainbow Medical Ltd. | Enhanced-diffusion capsule |
WO2010132331A2 (en) * | 2009-05-12 | 2010-11-18 | Proteus Biomedical, Inc. | Ingestible event markers comprising an ingestible component |
US8562589B2 (en) * | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
PL3461478T3 (pl) * | 2009-12-24 | 2020-09-21 | Rani Therapeutics, Llc | Połykalne urządzenie dostarczające lek |
PT2726091T (pt) * | 2011-06-29 | 2020-04-22 | Rani Therapeutics Llc | Preparações de agentes terapêuticos para administração num lúmen do trato intestinal utilizando um dispositivo de administração de fármacos de engolir |
EP2968071B1 (en) * | 2013-03-15 | 2021-08-04 | Rani Therapeutics, LLC | Device for oral delivery of therapeutic compounds |
US10227403B2 (en) * | 2014-05-15 | 2019-03-12 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
US10220076B2 (en) * | 2014-05-15 | 2019-03-05 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins |
US10064544B2 (en) * | 2015-01-26 | 2018-09-04 | The Chinese University Of Hong Kong | Endoscopic capsule and endoscopic system |
US10537453B2 (en) * | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
-
2019
- 2019-09-23 US US16/579,112 patent/US20200093740A1/en active Pending
- 2019-09-24 BR BR112021005449-9A patent/BR112021005449A2/pt unknown
- 2019-09-24 AU AU2019346545A patent/AU2019346545A1/en active Pending
- 2019-09-24 JP JP2021516679A patent/JP7334242B2/ja active Active
- 2019-09-24 KR KR1020217011936A patent/KR20210064298A/ko unknown
- 2019-09-24 WO PCT/US2019/052718 patent/WO2020068842A1/en unknown
- 2019-09-24 EP EP19866570.5A patent/EP3856153A4/en active Pending
- 2019-09-24 CN CN201980076623.8A patent/CN113164399A/zh active Pending
- 2019-09-24 CA CA3113987A patent/CA3113987A1/en active Pending
- 2019-09-24 MX MX2021003356A patent/MX2021003356A/es unknown
-
2023
- 2023-08-16 JP JP2023132432A patent/JP2023182567A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022502383A (ja) | 2022-01-11 |
BR112021005449A2 (pt) | 2021-06-15 |
EP3856153A1 (en) | 2021-08-04 |
WO2020068842A9 (en) | 2021-04-01 |
JP7334242B2 (ja) | 2023-08-28 |
KR20210064298A (ko) | 2021-06-02 |
WO2020068842A1 (en) | 2020-04-02 |
CN113164399A (zh) | 2021-07-23 |
US20200093740A1 (en) | 2020-03-26 |
EP3856153A4 (en) | 2022-06-29 |
CA3113987A1 (en) | 2020-04-02 |
AU2019346545A1 (en) | 2021-05-13 |
JP2023182567A (ja) | 2023-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021003356A (es) | Dispositivo ingerible con recinto expandible. | |
PH12020551420A1 (en) | Eartips and earphone devices, and systems and methods therefore | |
MX2020005537A (es) | Dispositivo y metodo para inseminacion artificial. | |
BR112019002641A2 (pt) | sistema de sutura endoscópico que tem canal de instrumentos externo | |
MY198468A (en) | An aerosol generating device and capsule | |
BR112018067896A2 (pt) | aparelho para administração sub-retinal de agente terapêutico através de uma agulha curva | |
GB2557854A (en) | Endoscopic systems, devices, and methods for performing in vivo procedures | |
MX2018007427A (es) | Dispositivo para tratamiento bucal. | |
MX349798B (es) | Dispositivo intrauterino. | |
JP2012502759A5 (es) | ||
EP2596738A4 (en) | ENDOSCOPE | |
NZ711546A (en) | Drug delivery devices with drug-permeable component and methods | |
MX2013011143A (es) | Conjunto de dispositivos de pesario. | |
NZ733181A (en) | Wound retractor and diffuser | |
MX2019006867A (es) | Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de integrina. | |
WO2019111132A4 (en) | Long acting gastric residence system | |
MX347258B (es) | Capsulas de liberacion sostenida. | |
NZ595629A (en) | Methods for preventing and/or treating lysosomal storage disorders | |
MX2018008306A (es) | Sistemas y metodos para un objeto iluminado con rasgos potenciados para animales. | |
EP3870261C0 (en) | INgestible device for delivery of a therapeutic agent to the gastro-intestinal tract | |
WO2016130800A3 (en) | Pharmaceutical compositions comprising perillyl alcohol derivatives | |
IL283822A (en) | A device for transporting an ingestible drug into the digestive tract of a user | |
MY195396A (en) | Treatment-instrument insertion aid | |
EP3600416C0 (en) | TREATMENT OF GASTROINTESTINAL DISEASE WITH AN IMMUNOMODULATORY AGENT RELEASED WITH AN INgestible Device. | |
EA201991362A1 (ru) | Щеточное устройство для биопсии, набор и способ |